Cart
sales@molnova.com
Sofosbuvir impurity G
CAS No. 1337482-15-1
Sofosbuvir impurity G( —— )
Catalog No. M26457 CAS No. 1337482-15-1
Sofosbuvir impurity G is both a diastereomer of Sofosbuvir and an impurity of Sofosbuvir which is an inhibitor of HCV RNA replication.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 2412 | In Stock |
|
| 10MG | 3267 | In Stock |
|
| 25MG | 4851 | In Stock |
|
| 50MG | 6561 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSofosbuvir impurity G
-
NoteResearch use only, not for human use.
-
Brief DescriptionSofosbuvir impurity G is both a diastereomer of Sofosbuvir and an impurity of Sofosbuvir which is an inhibitor of HCV RNA replication.
-
DescriptionSofosbuvir impurity G is both a diastereomer of Sofosbuvir and an impurity of Sofosbuvir which is an inhibitor of HCV RNA replication.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHCV
-
RecptorPARP1| PARP2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1337482-15-1
-
Formula Weight529.458
-
Molecular FormulaC22H29FN3O9P
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (188.88 mM)
-
SMILESCC(C)OC(=O)[C@H](C)N[P@](=O)(O[C@@H]1[C@@H](CO)O[C@@H](n2ccc(=O)[nH]c2=O)[C@]1(C)F)Oc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sch?fer P, Palacin T, Sidera M, Fletcher SP. Asymmetric Suzuki-Miyaura coupling of heterocycles via Rhodium-catalysed allylic arylation of racemates. Nat Commun. 2017 Jun 13;8:15762.
molnova catalog
related products
-
R-1479
A potent, specific inhibitor of HCV NS5B polymerase and HCV replication (IC50=1.28 uM, replicon assay).
-
R-7128
The prodrug of PSI-6130, a potent, specific inhibitor of HCV RNA synthesis by inhibiting the NS5B RNA polymerase.
-
Faldaprevir
A potent, selective noncovalent competitive inhibitor of HCV NS3/4A protease with Ki of 2.6 and 2.0 nM for GT1a and 1b NS3-NS4A protease, respectively.
